Patents by Inventor Christopher Whitehead

Christopher Whitehead has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240239764
    Abstract: This disclosure is in the field of medicinal chemistry, and relates to a new class of small-molecules having the Formula I, or a pharmaceutically acceptable salt or solvate thereof, or an enantiomer, a mixture of enantiomers, a mixture of two or more diastereomers, or an isotopic variant thereof, wherein the variables Ring A, X, R1a, R1b, R2, R3, R4, m, n, and p are described herein, which function as dual inhibitors of EGFR proteins and PI3K proteins. The disclosure further relates to the use of the compounds described herein as therapeutics for the treatment of diseases and conditions mediated by EGFR proteins and/or PI3K proteins, such as cancer and other diseases.
    Type: Application
    Filed: December 21, 2021
    Publication date: July 18, 2024
    Inventors: Christopher WHITEHEAD, Judith LEOPOLD
  • Patent number: 11999731
    Abstract: Provided herein are compounds that modulate EGFR and methods of using the same, for example to treat cancer.
    Type: Grant
    Filed: May 9, 2022
    Date of Patent: June 4, 2024
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Mukesh K. Nyati, Theodore S. Lawrence, Christopher Whitehead, Jason Christopher Rech, Brennan Taylor Watch
  • Publication number: 20230097789
    Abstract: Provided herein are compounds that are useful in treating cancer.
    Type: Application
    Filed: March 5, 2021
    Publication date: March 30, 2023
    Inventors: Mukesh K. Nyati, Theodore S. Lawrence, Christopher Whitehead, Jason Christopher Rech, Brennan Taylor Watch, Alexander Bridges
  • Publication number: 20220340572
    Abstract: Provided herein are compounds that modulate EGFR and methods of using the same, for example to treat cancer.
    Type: Application
    Filed: May 9, 2022
    Publication date: October 27, 2022
    Inventors: Mukesh K. Nyati, Theodore S. Lawrence, Christopher Whitehead, Jason Christopher Rech, Brennan Taylor Watch
  • Patent number: 11358965
    Abstract: Provided herein are compounds that modulate EGFR and methods of using the same, for example to treat cancer.
    Type: Grant
    Filed: February 25, 2019
    Date of Patent: June 14, 2022
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Mukesh K. Nyati, Theodore S. Lawrence, Christopher Whitehead, Jason Christopher Rech, Brennan Taylor Watch
  • Patent number: 10857883
    Abstract: A system that includes an accelerometer configured to measure acceleration of a vehicle, a gyroscope configured to measure orientation of the vehicle, a memory having computer readable instructions, and a processor for executing the computer readable instructions. The computer readable instructions include performing at intervals: receiving acceleration data from the accelerometer; receiving orientation data from the gyroscope; combining the acceleration data and the orientation data to generate speed fluctuation and slope data for the vehicle; and transmitting the fluctuation and slope data to a controller of the vehicle. The controller utilizes the speed fluctuation and slope data to modulate an engine throttle of the vehicle.
    Type: Grant
    Filed: November 13, 2017
    Date of Patent: December 8, 2020
    Assignee: THE UNIVERSITY OF MASSACHUSETTS
    Inventors: Sam Mil'shtein, Christopher Whitehead, HarshaPurushothama Dombala
  • Publication number: 20200377503
    Abstract: Provided herein are compounds that modulate EGFR and methods of using the same, for example to treat cancer.
    Type: Application
    Filed: February 25, 2019
    Publication date: December 3, 2020
    Inventors: Mukesh K. Nyati, Theodore S. Lawrence, Christopher Whitehead, Jason Christopher Rech, Brennan Taylor Watch
  • Publication number: 20180134157
    Abstract: A system that includes an accelerometer configured to measure acceleration of a vehicle, a gyroscope configured to measure orientation of the vehicle, a memory having computer readable instructions, and a processor for executing the computer readable instructions. The computer readable instructions include performing at intervals: receiving acceleration data from the accelerometer; receiving orientation data from the gyroscope; combining the acceleration data and the orientation data to generate speed fluctuation and slope data for the vehicle; and transmitting the fluctuation and slope data to a controller of the vehicle. The controller utilizes the speed fluctuation and slope data to modulate an engine throttle of the vehicle.
    Type: Application
    Filed: November 13, 2017
    Publication date: May 17, 2018
    Inventors: Sam Mil'shtein, Christopher Whitehead, HarshaPurushothama Dombala
  • Patent number: 9611258
    Abstract: Dual inhibitors of MEK and PI3K and compositions containing the same are disclosed. Methods of using the dual MEK/PI3K inhibitors in the treatment of diseases and conditions wherein inhibition of MEK and PI3K provides a benefit, like cancers, also are disclosed.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: April 4, 2017
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Brian D. Ross, Marcian Van Dort, Christopher Whitehead
  • Publication number: 20160002212
    Abstract: Dual inhibitors of MEK and PI3K and compositions containing the same are disclosed. Methods of using the dual MEK/PI3K inhibitors in the treatment of diseases and conditions wherein inhibition of MEK and PI3K provides a benefit, like cancers, also are disclosed.
    Type: Application
    Filed: March 12, 2014
    Publication date: January 7, 2016
    Inventors: Brian D. Ross, Marcian Van Dort, Christopher Whitehead
  • Publication number: 20090324443
    Abstract: In one aspect, the invention provides a gas treatment apparatus (1) comprising a gas-flow path and a plurality of reactor units (5)-(7) through which gas to be treated may flow arranged in series along the path. The reactor units (5)-(7) are adapted to generate a non-equilibrium plasma. This aspect of the invention may be used for decomposing pollutant materials in a gas (e.g. air). When air is being treated, the apparatus of this aspect of the invention is advantageously provided, downstream of the final reactor unit in series, with at least one catalyst bed (8) incorporating a catalyst capable of decomposing ozone.
    Type: Application
    Filed: February 19, 2007
    Publication date: December 31, 2009
    Inventors: John Christopher Whitehead, Kui Zhang, David John Glover
  • Publication number: 20050026964
    Abstract: The present invention relates to 5-substituted-4-(substituted)phenylamino-2-pyridone derivatives, pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: June 24, 2004
    Publication date: February 3, 2005
    Inventors: Shannon Black, Michael Kaufman, Daniel Ortwine, Mark Plummer, John Quin, Gordon Rewcastle, Aurash Shahripour, Julie Spicer, Christopher Whitehead
  • Publication number: 20050008492
    Abstract: Percussive impacts due to bird strikes upon the hollow fan blades 20 are a well known problem. These percussive impacts not only deform previous fan blades but also reduce their stiffness. In accordance with the present invention, hollow fan blades 20 incorporate a cavity 23 within which, a matrix 24 with embedded expandable elements 25, is located. Thus, upon a percussive impact these expandable elements 25 are released in order to create an internal pressure within the cavity 25 which acts outwardly in order to relieve deformation and also stiffen the blade 20 as a result of the over pressure within the cavity 23.
    Type: Application
    Filed: June 22, 2004
    Publication date: January 13, 2005
    Inventors: Christopher Whitehead, Simon Read